International Biotechnology (LON:IBT) Stock Crosses Above 200-Day Moving Average – Here’s What Happened

International Biotechnology (LON:IBT) crossed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of GBX 945.04 and traded as high as GBX 970. International Biotechnology shares last traded at GBX 966, with a volume of 39,518 shares trading hands.

International Biotechnology Price Performance

The company’s 50 day moving average price is GBX 962.80 and its 200-day moving average price is GBX 945.10. The company has a market capitalization of £303.64 million, a PE ratio of -289.97 and a beta of 0.32. The company has a current ratio of 0.11, a quick ratio of 0.32 and a debt-to-equity ratio of 9.43.

International Biotechnology (LON:IBT) last announced its quarterly earnings results on Tuesday, May 12th. The company reported GBX (4.83) earnings per share for the quarter. International Biotechnology had a return on equity of 27.35% and a net margin of 82.27%.The business had revenue of GBX 24 million for the quarter. On average, sell-side analysts forecast that International Biotechnology will post 0.9435943 earnings per share for the current fiscal year.

International Biotechnology Company Profile

The Company’s investment objective is to achieve long-term capital growth by investing in biotechnology and other life sciences companies.

The Company will seek to achieve its objective by investing in a diversified portfolio of companies which may be quoted or unquoted and whose shares are considered to have good growth prospects, with experienced management and strong potential upside through the development and/or commercialisation of a product, device or enabling technology. Investments may also be made in related sectors such as medical devices and healthcare services.